Back
Summit Therapeutics Stock Predictions
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market
Buy
85
SMMT
Summit Therapeutics
Last Price:
26.20
Seasonality Move:
26.72%
7 Day Trial
ALL ACCESS PASS
$
7
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Summit Therapeutics Stock Forecast
- Over the next 52 weeks, Summit Therapeutics has on average historically risen by 178.3% based on the past 9 years of stock performance.
- Summit Therapeutics has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
-
Is Summit Therapeutics Stock Undervalued?
The current Summit Therapeutics [SMMT] share price is $29.48. The Score for SMMT is 85, which is 70% above its historic median score of 50, and infers lower risk than normal. - SMMT is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
Will Summit Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Summit Therapeutics has on average historically risen by 178.3% based on the past 9 years of stock performance.
Summit Therapeutics Stock Rating
Buy
85
Summit Therapeutics (SMMT)
is a Buy
Is Summit Therapeutics overpriced?
- Summit Therapeutics has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
Summit Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
smmttx.com
52-Week Data
52-Week High:
33.89
52-Week Low:
1.64
Prediction Charts
Market Cap:
21.66B
Price in USD:
29.48
Volume:
14.64M
Beta:
-0.28
Technical Analysis
SMA50:
12.66
SMA100:
9.39
SMA200:
6.49
52-Wk Change:
1476.47%
Stock Predictions
-
Is Summit Therapeutics stock public?
Yes, Summit Therapeutics is a publicly traded company. -
What is the Summit Therapeutics stock quote today?
The Summit Therapeutics stock price is 29.48 USD today. -
How to buy Summit Therapeutics stock online?
You can buy Summit Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Aug-28 | 13.56 | 13.12 | 13.70 | 12.89 |
| Aug-29 | 13.24 | 12.86 | 14.02 | 12.43 |
| Aug-30 | 12.92 | 12.98 | 13.25 | 12.36 |
| Sep-3 | 12.98 | 12.61 | 13.08 | 12.02 |
| Sep-4 | 12.43 | 12.00 | 12.73 | 11.88 |
| Sep-5 | 12.05 | 12.51 | 12.51 | 11.76 |
| Sep-6 | 12.52 | 12.27 | 12.93 | 11.88 |
| Sep-9 | 16.06 | 19.14 | 21.50 | 15.95 |
| Sep-10 | 19.28 | 22.97 | 23.10 | 17.72 |
| Sep-11 | 22.63 | 22.69 | 24.07 | 22.00 |
| Sep-12 | 24.69 | 27.41 | 28.62 | 24.36 |
| Sep-13 | 27.50 | 31.93 | 33.60 | 27.41 |
| Sep-16 | 32.52 | 29.48 | 33.89 | 28.73 |
| Sep-17 | 28.44 | 26.22 | 29.09 | 25.61 |
Summit Therapeutics Earnings
Summit Therapeutics Earnings Report: Per Share Summit Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Summit Therapeutics Forecast Revenue Growth
Summit Therapeutics Stock Analysis: Historical quarterly revenues per share for Summit Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.32 per share, and a decrease next year of $0.03 per share.
* Summit Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.